Health Care & Life Sciences » Medical Equipment & Supplies | Baxter International Inc.

Baxter International Inc. | Cash Flow

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,012
2,497
968
4,965
717
1,624
Depreciation, Depletion & Amortization
823
792
759
752
751
776
Other Funds
485
356
1,964
292
308
323
Funds from Operations
3,444
3,629
2,110
1,830
2,019
2,456
Changes in Working Capital
246
414
339
176
182
360
Net Operating Cash Flow
3,198
3,215
1,771
1,654
1,837
2,096
Capital Expenditures
1,525
925
911
719
634
Net Investing Cash Flow
5,362
1,542
1,807
715
1,310
Cash Dividends Paid - Total
1,023
1,095
910
268
315
Issuance/Reduction of Debt, Net
3,096
113
2,393
56
632
Net Financing Cash Flow
1,645
1,402
481
324
61
Net Change in Cash
537
192
712
588
593
Free Cash Flow
1,673
2,290
860
935
1,203
Deferred Taxes & Investment Tax Credit
224
117
50
302
211
267
Net Assets from Acquisitions
3,851
95
34
48
686
Other Sources
14
99
84
52
10
Change in Capital Stock
913
550
-
292
564
Exchange Rate Effect
18
79
195
27
5
Other Uses
-
621
946
-
-

About Baxter International

View Profile
Address
One Baxter Parkway
Deerfield Illinois 60015
United States
Employees -
Website http://www.baxter.com
Updated 07/08/2019
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.